Annual ROA
-53.85%
+70.93%+56.84%
31 December 2023
Summary:
GT Biopharma annual return on assets is currently -53.85%, with the most recent change of +70.93% (+56.84%) on 31 December 2023. During the last 3 years, it has risen by +445.99% (+89.23%). GTBP annual ROA is now -100.14% below its all-time high of 39.07 thousand%, reached on 31 December 2016.GTBP ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-123.35%
-31.48%-34.27%
30 September 2024
Summary:
GT Biopharma quarterly return on assets is currently -123.35%, with the most recent change of -31.48% (-34.27%) on 30 September 2024. Over the past year, it has dropped by -65.87% (-114.60%). GTBP quarterly ROA is now -100.61% below its all-time high of 20.25 thousand%, reached on 31 March 2016.GTBP Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +56.8% | -114.6% |
| 3 y3 years | +89.2% | +27.6% |
| 5 y5 years | +94.7% | +42.6% |
GTBP ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +89.2% | -178.0% | +28.1% |
| 5 y | 5 years | at high | +99.5% | -178.0% | +98.6% |
| alltime | all time | -100.1% | +99.5% | -100.6% | +99.0% |
GT Biopharma ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -123.35%(+34.3%) |
| June 2024 | - | -91.87%(+39.0%) |
| Mar 2024 | - | -66.10%(+49.0%) |
| Dec 2023 | -53.85%(-56.8%) | -44.37%(-22.8%) |
| Sept 2023 | - | -57.48%(-25.6%) |
| June 2023 | - | -77.25%(+1.1%) |
| Mar 2023 | - | -76.39%(-18.2%) |
| Dec 2022 | -124.78%(-30.8%) | -93.42%(-26.5%) |
| Sept 2022 | - | -127.12%(+19.1%) |
| June 2022 | - | -106.69%(+6.6%) |
| Mar 2022 | - | -100.10%(-41.7%) |
| Dec 2021 | -180.34%(-63.9%) | -171.67%(+0.8%) |
| Sept 2021 | - | -170.36%(-28.1%) |
| June 2021 | - | -236.92%(-62.9%) |
| Mar 2021 | - | -637.85%(-55.3%) |
| Dec 2020 | -499.84%(-94.9%) | -1426.21%(-59.4%) |
| Sept 2020 | - | -3515.69%(-61.1%) |
| June 2020 | - | -9030.05%(+1592.9%) |
| Mar 2020 | - | -533.41%(+79.9%) |
| Dec 2019 | -9759.34%(+856.4%) | -296.58%(+38.1%) |
| Sept 2019 | - | -214.75%(-77.6%) |
| June 2019 | - | -958.75%(+214.2%) |
| Mar 2019 | - | -305.10%(+66.1%) |
| Dec 2018 | -1020.46%(+1700.4%) | -183.73%(+39.6%) |
| Sept 2018 | - | -131.60%(+116.1%) |
| June 2018 | - | -60.91%(-21.6%) |
| Mar 2018 | - | -77.68%(-31.1%) |
| Dec 2017 | -56.68%(-100.1%) | -112.82%(-48.6%) |
| Sept 2017 | - | -219.57%(-98.2%) |
| June 2017 | - | -12.03 K%(+136.6%) |
| Mar 2017 | - | -5082.29%(-176.0%) |
| Dec 2016 | 39.07 K%(-958.7%) | 6690.41%(-176.0%) |
| Sept 2016 | - | -8800.00%(-4.4%) |
| June 2016 | - | -9201.59%(-145.4%) |
| Mar 2016 | - | 20.25 K%(-492.1%) |
| Dec 2015 | -4550.11%(+0.2%) | -5164.10%(+130.3%) |
| Sept 2015 | - | -2242.82%(-12.9%) |
| June 2015 | - | -2574.37%(-62.5%) |
| Mar 2015 | - | -6865.01%(+11.1%) |
| Dec 2014 | -4538.94%(+1589.7%) | -6181.32%(+155.0%) |
| Sept 2014 | - | -2424.12%(+92.3%) |
| June 2014 | - | -1260.62%(+9.1%) |
| Mar 2014 | - | -1155.82%(+219.8%) |
| Dec 2013 | -268.63%(-90.8%) | -361.39%(-49.0%) |
| Sept 2013 | - | -708.33%(-49.6%) |
| June 2013 | - | -1405.77%(-50.3%) |
| Mar 2013 | - | -2827.11%(-19.7%) |
| Dec 2012 | -2913.24%(+23.6%) | -3522.48%(+11.6%) |
| Sept 2012 | - | -3155.86%(+55.9%) |
| June 2012 | - | -2024.04%(+74.5%) |
| Mar 2012 | - | -1160.04%(-34.2%) |
| Dec 2011 | -2356.69%(+517.3%) | -1761.90%(+36.6%) |
| Sept 2011 | - | -1289.60%(+4.1%) |
| June 2011 | - | -1238.83%(+98.8%) |
| Mar 2011 | - | -623.12%(+46.0%) |
| Dec 2010 | -381.77%(+67.8%) | -426.76%(-9.0%) |
| Sept 2010 | - | -468.95%(+19.9%) |
| June 2010 | - | -391.03%(-21.1%) |
| Mar 2010 | - | -495.36%(+66.0%) |
| Dec 2009 | -227.56%(+23.8%) | -298.43%(+28.9%) |
| Sept 2009 | - | -231.52%(-7.9%) |
| June 2009 | - | -251.37%(-2.6%) |
| Mar 2009 | - | -257.99%(+28.2%) |
| Dec 2008 | -183.81%(-2607.6%) | -201.29%(+68.9%) |
| Sept 2008 | - | -119.20%(+49.6%) |
| June 2008 | - | -79.67%(-2764.5%) |
| Mar 2008 | - | 2.99%(-63.8%) |
| Dec 2007 | 7.33%(-111.7%) | 8.27%(-118.3%) |
| Sept 2007 | - | -45.21%(-10.4%) |
| June 2007 | - | -50.44%(-27.7%) |
| Mar 2007 | - | -69.75%(+10.0%) |
| Dec 2006 | -62.52%(+63.7%) | -63.43%(+11.6%) |
| Sept 2006 | - | -56.82%(+4.5%) |
| June 2006 | - | -54.36%(+5.1%) |
| Mar 2006 | - | -51.70%(+16.0%) |
| Dec 2005 | -38.19%(-26.1%) | -44.56%(+53.5%) |
| Sept 2005 | - | -29.02%(+6.5%) |
| June 2005 | - | -27.26%(-47.7%) |
| Mar 2005 | - | -52.17%(-31.1%) |
| Dec 2004 | -51.69% | -75.67%(-17.0%) |
| Sept 2004 | - | -91.20%(-10.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2004 | - | -102.24%(+60.2%) |
| Mar 2004 | - | -63.81%(+56.4%) |
| Dec 2003 | -40.07%(-9.7%) | -40.80%(+8.9%) |
| Sept 2003 | - | -37.48%(-11.8%) |
| June 2003 | - | -42.51%(+26.3%) |
| Mar 2003 | - | -33.67%(-7.6%) |
| Dec 2002 | -44.36%(-53.4%) | -36.44%(-7.7%) |
| Sept 2002 | - | -39.48%(-2.9%) |
| June 2002 | - | -40.65%(-57.2%) |
| Mar 2002 | - | -94.92%(-12.4%) |
| Dec 2001 | -95.15%(+9.8%) | -108.31%(-2.2%) |
| Sept 2001 | - | -110.71%(+12.2%) |
| June 2001 | - | -98.63%(+35.9%) |
| Mar 2001 | - | -72.55%(+6.6%) |
| Dec 2000 | -86.67%(+58.0%) | -68.06%(+25.6%) |
| Sept 2000 | - | -54.18%(-1.9%) |
| June 2000 | - | -55.21%(-16.4%) |
| Mar 2000 | - | -66.02%(+3.7%) |
| Dec 1999 | -54.87%(-8.0%) | -63.67%(-7.5%) |
| Sept 1999 | - | -68.85%(+1.4%) |
| June 1999 | - | -67.88%(+19.8%) |
| Mar 1999 | - | -56.64%(-1.4%) |
| Dec 1998 | -59.66%(+18.2%) | -57.47%(+11.5%) |
| Sept 1998 | - | -51.52%(+7.4%) |
| June 1998 | - | -47.96%(-14.8%) |
| Mar 1998 | - | -56.32%(+4.2%) |
| Dec 1997 | -50.49%(-24.7%) | -54.05%(-16.0%) |
| Sept 1997 | - | -64.37%(-1.4%) |
| June 1997 | - | -65.27%(-4.0%) |
| Mar 1997 | - | -68.02%(+2.1%) |
| Dec 1996 | -67.04%(-20.5%) | -66.59%(+0.1%) |
| Sept 1996 | - | -66.52%(-31.8%) |
| June 1996 | - | -97.56%(+4.5%) |
| Mar 1996 | - | -93.39%(+11.4%) |
| Dec 1995 | -84.36%(+7.7%) | -83.80%(+17.3%) |
| Sept 1995 | - | -71.43%(-7.2%) |
| June 1995 | - | -77.00%(+2.3%) |
| Mar 1995 | - | -75.24%(-10.8%) |
| Dec 1994 | -78.32%(+108.9%) | -84.34%(-12.2%) |
| Sept 1994 | - | -96.08%(+260.8%) |
| June 1994 | - | -26.63%(-39.8%) |
| Mar 1994 | - | -44.20%(+18.4%) |
| Dec 1993 | -37.50%(+505.8%) | -37.33%(+4.5%) |
| Sept 1993 | - | -35.71%(+46.9%) |
| June 1993 | - | -24.31%(+292.7%) |
| Mar 1993 | - | -6.19%(-26.5%) |
| Dec 1992 | -6.19%(+51.7%) | -8.42%(+32.6%) |
| Sept 1992 | - | -6.35%(+2.6%) |
| June 1992 | - | -6.19%(+0.5%) |
| Mar 1992 | - | -6.16%(+55.6%) |
| Dec 1991 | -4.08%(-121.3%) | -3.96%(-304.1%) |
| Sept 1991 | - | 1.94%(-51.5%) |
| June 1991 | - | 4.00%(-71.4%) |
| Mar 1991 | - | 14.00%(-30.0%) |
| Dec 1990 | 19.15%(+8.1%) | 20.00%(-2.2%) |
| Sept 1990 | - | 20.45%(+12.5%) |
| June 1990 | - | 18.18%(0.0%) |
| Mar 1990 | - | 18.18%(+14.3%) |
| Dec 1989 | 17.72%(+502.7%) | 15.91%(-7.2%) |
| Sept 1989 | - | 17.14%(0.0%) |
| June 1989 | - | 17.14%(+100.0%) |
| Mar 1989 | - | 8.57%(+199.7%) |
| Dec 1988 | 2.94%(-67.7%) | 2.86%(-52.8%) |
| Sept 1988 | - | 6.06%(+100.0%) |
| June 1988 | - | 3.03%(>+9900.0%) |
| Mar 1988 | - | 0.00%(-100.0%) |
| Dec 1987 | 9.09%(-173.8%) | 6.06%(-200.0%) |
| Sept 1987 | - | -6.06%(0.0%) |
| June 1987 | - | -6.06%(-50.0%) |
| Mar 1987 | - | -12.12%(0.0%) |
| Dec 1986 | -12.31%(+43.6%) | -12.12%(+29.2%) |
| Sept 1986 | - | -9.38%(+199.7%) |
| June 1986 | - | -3.13%(<-9900.0%) |
| Mar 1986 | - | 0.00%(-100.0%) |
| Dec 1985 | -8.57%(-271.4%) | -9.38%(<-9900.0%) |
| Sept 1985 | - | 0.00%(-100.0%) |
| June 1985 | - | -2.63%(-200.0%) |
| Mar 1985 | - | 2.63%(-50.0%) |
| Dec 1984 | 5.00%(-30.0%) | - |
| Dec 1984 | - | 5.26% |
| Feb 1984 | 7.14% | - |
FAQ
- What is GT Biopharma annual return on assets?
- What is the all time high annual ROA for GT Biopharma?
- What is GT Biopharma annual ROA year-on-year change?
- What is GT Biopharma quarterly return on assets?
- What is the all time high quarterly ROA for GT Biopharma?
- What is GT Biopharma quarterly ROA year-on-year change?
What is GT Biopharma annual return on assets?
The current annual ROA of GTBP is -53.85%
What is the all time high annual ROA for GT Biopharma?
GT Biopharma all-time high annual return on assets is 39.07 K%
What is GT Biopharma annual ROA year-on-year change?
Over the past year, GTBP annual return on assets has changed by +70.93% (+56.84%)
What is GT Biopharma quarterly return on assets?
The current quarterly ROA of GTBP is -123.35%
What is the all time high quarterly ROA for GT Biopharma?
GT Biopharma all-time high quarterly return on assets is 20.25 K%
What is GT Biopharma quarterly ROA year-on-year change?
Over the past year, GTBP quarterly return on assets has changed by -65.87% (-114.60%)